Nanoviricides NNVC
NYSE NNVC
$1.01 -0.02 (-2.39%)
As of: Sep 10, 2026 · 3:59 PM EDT

Nanoviricides (NNVC) Other Non-Current Assets (2013 - 2023)

Nanoviricides' (NNVC) quarterly Other Non-Current Assets came in at $14361.0 in Q2 2023, down 66.16% year-over-year from $42440.0 in Q2 2022, and down 25.14% quarter-over-quarter from $19183.0 in Q1 2023.

Analysis

Nanoviricides (NNVC) Other Non-Current Assets (2013 - 2023) Analysis & Trends

Nanoviricides has disclosed Other Non-Current Assets across 11 years of filings, most recently posting $14361.0 for Q2 2023.

  • In Q2 2023, Other Non-Current Assets fell 66.16% year-over-year to $14361.0; the TTM figure through Jun 2023 stood at $14361.0 (down 66.16% YoY), while the FY2023 annual figure was $14361.0, down 66.16% from the prior year.
  • Other Non-Current Assets came in at $14361.0 for Q2 2023 at Nanoviricides, down from $19183.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $62977.0 in Q3 2020 to a low of $3515.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $21966.6, with a median of $20275.0 recorded in 2019.
  • Year-over-year, Other Non-Current Assets slumped 94.42% in 2021 and surged 1300.2% in 2022.
  • Over 5 years, Other Non-Current Assets stood at $21367.0 in 2019, then sank by 72.61% to $5853.0 in 2020, then sank by 39.95% to $3515.0 in 2021, then soared by 654.2% to $26510.0 in 2022, then slumped by 45.83% to $14361.0 in 2023.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $14361.0 in Q2 2023, $19183.0 in Q1 2023, and $26510.0 in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 12.98 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 4.75 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 2.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 124.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 618.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 65.13 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 831.80 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 29.59 Mn
10 Nanoviricides 22.04 Mn 18.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 14,361.00
Mar 31, 2023 19,183.00
Dec 31, 2022 26,510.00
Sep 30, 2022 35,588.00
Jun 30, 2022 42,440.00
Mar 31, 2022 49,217.00
Dec 31, 2021 3,515.00
Sep 30, 2021 3,515.00
Jun 30, 2021 3,515.00
Mar 31, 2021 3,515.00
Dec 31, 2020 5,853.00
Sep 30, 2020 62,977.00
Jun 30, 2020 25,863.00
Mar 31, 2020 17,499.00
Dec 31, 2019 21,367.00
Sep 30, 2019 25,277.00
Jun 30, 2019 29,187.00
Mar 31, 2019 6,017.00
Dec 31, 2018 5,312.00
Sep 30, 2018 6,737.00